Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Regulatory Filings 2021

Oct 12, 2021

59231_rns_2021-10-12_a9cefe02-3f84-44de-9607-d32ada1d14ae.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [178 x 49] intentionally omitted <==

12th October, 2021

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai 400 051 Mumbai 400 001 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Sub: Certificate in terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 30[th] September, 2021.

This is with reference to captioned subject, we wish to enclose herewith the certificate issued by the Registrar and Share Transfer Agent of the Company viz. Link Intime India Private Limited, in terms of the provisions of the said regulations, for the quarter ended on 30[th] September, 2021.

Kindly acknowledge receipt of the same.

Thanking you,

For Wockhardt Limited

==> picture [115 x 56] intentionally omitted <==

Debashis Dey Company Secretary

Encl: As above

==> picture [113 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==